Pharmafile Logo
Pharmafocus logo
Advanced Search

Vernalis

Showing 5 posts of 5 posts found.

fda_building_web

Vernalis cough and cold drug knocked-back by FDA

August 7, 2017
Sales and Marketing Vernalis, biotech, drugs, pharma, pharmaceutical, tris pharma

Vernalis has been given a second CRL for a cough and cold treatment by the FDA this year. The therapy, …

News

Vernalis diabetes pain drug fails in phase II

March 24, 2010
Research and Development Vernalis

Vernalis’ new treatment for neuropathic pain has disappointed in phase II trials and will now be dropped for this indication. …

News

Vernalis and GSK sign risk-sharing deal

August 7, 2009
Research and Development, Sales and Marketing Deals, GSK, Vernalis

Vernalis and GlaxoSmithKline have joined forces to work on a cancer treatment in a deal which could be worth more …

News

Servier signs drug discovery deal with Vernalis

May 7, 2009
Research and Development, Sales and Marketing Servier, Vernalis

Servier, France's largest privately-owned pharma company, has signed a new three-year drug discovery deal with Vernalis focused on oncology. UK …

News

Vernalis takes diabetes pain drug into phase II

August 15, 2006
Research and Development Vernalis

UK biotech company Vernalis has started enrolment into a phase II trial of V3381, a drug designed for patients with …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025